The tennis star has sparked an online debate about whether or not using GLP-1s for weight loss is taking the easy way out.

Health insurance will grow more expensive in many corners of the market in 2026, and some coverage may shrink.

GreensKeeper Asset Management, an investment management company, released its second-quarter 2025 investor letter. A copy of ...

Burke Wealth Management, an investment management company, released its “Focused Growth Strategy” second-quarter 2025 ...

Millions of Americans who have dropped pounds and boosted their health using popular obesity drugs like Wegovy are facing a ...

A new study led by the Kinsey Institute analyzed how GLP-1 weight-loss drugs are changing people’s dating lives.

The mad rush for safe and effective obesity drugs has winners—including Eli Lilly’s Zepbound and Novo Nordisk’s Wegovy—and ...

Serena Williams' weight loss was aided GLP-1 medication for weight loss, losing 31 pounds. The tennis legend speaks on ...

Serena Williams has revealed she lost 31 pounds on the GLP-1 Zepbound: "I just couldn't get my weight to where I needed to be at a healthy place." ...

A new imaging approach reveals how dual agonist drugs like tirzepatide act on the pancreas and brain to regulate blood sugar and appetite.

Tennis champion Serena Williams has divided the internet after revealing she’s been using a GLP-1 weight loss drug. The ...

Serena Williams turned to a weight loss medication and it is paying off massively as the American tennis icon reveals she ...